Four Histological Disease-Activity Indices Similarly Reliable in Ulcerative Colitis Four Histological Disease-Activity Indices Similarly Reliable in Ulcerative Colitis
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 20, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

https://www.sierraclub.org/sierra/PFAS-toxin-every-household-states-sue-chemical-companies
Medical studies have linked PFAS in drinking water to kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, pancreatic cancer and birth defects.08/13/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 13, 2018 Category: Urology & Nephrology Source Type: news

Impact of Opioid Epidemic on IBD: Patients Are at Risk Impact of Opioid Epidemic on IBD: Patients Are at Risk
The impact of the opioid epidemic in patients with ulcerative colitis and Crohn disease is front and center at DDW 2018.Medscape Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 6, 2018 Category: Consumer Health News Tags: Gastroenterology Commentary Source Type: news

European Union Clears Tofacitinib for Ulcerative Colitis European Union Clears Tofacitinib for Ulcerative Colitis
The JAK inhibitor is indicated for adults with moderately to severely active ulcerative colitis who have failed to respond adequately to or are intolerant of other therapies.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 2, 2018 Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news

Methotrexate No Better Than Placebo for Steroid-Free Response, Remission in UC Methotrexate No Better Than Placebo for Steroid-Free Response, Remission in UC
Subcutaneous methotrexate (MTX) may not work better than placebo as maintenance therapy for ulcerative colitis (UC), researchers have found.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 28, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Sustained Response to Golimumab Predicts Good Outcomes in Ulcerative Colitis Sustained Response to Golimumab Predicts Good Outcomes in Ulcerative Colitis
Continuous clinical response (CCR) to golimumab treatment is associated with favorable outcomes in patients with moderate to severe ulcerative colitis (UC), according to a post hoc analysis of the PURSUIT-M trial.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 26, 2018 Category: Surgery Tags: Gastroenterology News Source Type: news

Researchers find link between viruses, inflammatory bowel diseases
Viruses and inflammatory bowel diseases, including ulcerative colitis and Crohn's disease, have a key connection, according to a study with mice. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 23, 2018 Category: Consumer Health News Source Type: news

Researchers find connection between viruses and inflammatory bowel disease
(University of Colorado Anschutz Medical Campus) A study led by a researcher at the University of Colorado Anschutz Medical Campus reveals a key connection between viruses and inflammatory bowel diseases like ulcerative colitis and Crohn's disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2018 Category: Infectious Diseases Source Type: news

Obesity and Treatment Failure in Biologic-Treated UC Patients Obesity and Treatment Failure in Biologic-Treated UC Patients
How does obesity impact real world response to biological therapy in patients with ulcerative colitis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Acetaminophen, NSAIDs and Risk of IBD Exacerbation Acetaminophen, NSAIDs and Risk of IBD Exacerbation
Does the use of NSAIDs or COX-2 inhibitors exacerbate Crohn's disease or ulcerative colitis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 10, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Medical News Today: What is dexamethasone?
Dexamethasone oral tablet is a prescription medication used to treat conditions such as inflammation, allergic reactions, ulcerative colitis, and adrenal insufficiency. It's available as a generic drug and as the brand-name drugs DexPak and Decadron. Learn about side effects, warnings, dosage, and more. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 10, 2018 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

Gender-bending chemical may cause inflammatory bowel disease
Researchers from Texas A&M University found that exposure to bisphenol A (BPA) causes the same inflammation and gut bacteria changes in mice that occur in Crohn's and ulcerative colitis patients. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2018 Category: Consumer Health News Source Type: news

Exposure to a gender-bending chemical found in bank notes may cause inflammatory bowel disease
Researchers from Texas A&M University found that exposure to bisphenol A (BPA) causes the same inflammation and gut bacteria changes in mice that occur in Crohn's and ulcerative colitis patients. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2018 Category: Consumer Health News Source Type: news

Immune cells that create and sustain chronic inflammatory bowel disease identified
(University of Alabama at Birmingham) In preclinical experiments, Laurie Harrington and colleagues have discovered a subset of immune cells that create and sustain chronic inflammatory bowel disease. These cells could become potential therapeutic targets to ameliorate or cure Crohn's disease and ulcerative colitis. Furthermore, if this subset of CD4 T cells plays a similar role in other autoimmune diseases, such as Type 1 diabetes or rheumatoid arthritis, they could also be targets for therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 26, 2018 Category: International Medicine & Public Health Source Type: news

Adalimumab Best on Costs in Ulcerative Colitis
(MedPage Today) -- Study conducted in Canada (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 5, 2018 Category: Gastroenterology Source Type: news

Early Response Seen for Apremilast in Ulcerative Colitis
(MedPage Today) -- 12-week results with agent best known as psoriasis drug (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 5, 2018 Category: Gastroenterology Source Type: news

Arthritis and asthma sufferers may be up to one-third less likely to develop Parkinson's disease
Researchers from the University of Washington found people who take  corticosteroids, which are commonly prescribed for psoriasis and ulcerative colitis, are 20 percent less at risk of suffering tremors. (Source: the Mail online | Health)
Source: the Mail online | Health - May 31, 2018 Category: Consumer Health News Source Type: news

New Treatment for Ulcerative Colitis Approved
Title: New Treatment for Ulcerative Colitis ApprovedCategory: Health NewsCreated: 5/30/2018 12:00:00 AMLast Editorial Review: 5/31/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 31, 2018 Category: Nutrition Source Type: news

FDA green lights Pfizer drug for ulcerative colitis
The FDA has expanded its approval for Pfizer ’s drug Xeljanz. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - May 30, 2018 Category: Pharmaceuticals Source Type: news

Tofacitinib (Xeljanz) Gets FDA Nod for Ulcerative Colitis Tofacitinib (Xeljanz) Gets FDA Nod for Ulcerative Colitis
The FDA has expanded the indication for tofacitinib to include adults with moderate to severe active ulcerative colitis, making it the first oral medication approved for long-term use in ulcerative colitis.FDA Approvals (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 30, 2018 Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news

FDA Approves New Treatment for Ulcerative Colitis
WEDNESDAY, May 30, 2018 -- U.S. Food and Drug Administration approval of Xeljanz (tofacitinib) has been expanded to include adults with active moderate-to-severe ulcerative colitis, the agency said Wednesday. Xeljanz was first approved in 2012 for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 30, 2018 Category: Pharmaceuticals Source Type: news

Tofacitinib Gains Ulcerative Colitis Indication
(MedPage Today) -- Oral JAK inhibitor expands treatment options (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 30, 2018 Category: Gastroenterology Source Type: news

FDA clears Pfizer's Xeljanz for inflammatory bowel disease
(Reuters) - The U.S. Food and Drug Administration said on Wednesday that it had approved Pfizer Inc's drug, Xeljanz, to treat adults with moderate-to-severe active ulcerative colitis. (Source: Reuters: Health)
Source: Reuters: Health - May 30, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves new treatment for moderately to severely active ulcerative colitis
FDA today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. (Source: Food and Drug Administration)
Source: Food and Drug Administration - May 30, 2018 Category: American Health Source Type: news

Xeljanz (Tofacitinib) Approved for Ulcerative Colitis
WEDNESDAY, May 30, 2018 -- U.S. Food and Drug Administration approval of Xeljanz (tofacitinib) has been expanded to include adults with active moderate-to-severe ulcerative colitis, the agency said Wednesday. Ulcerative colitis (UC) is a chronic... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 30, 2018 Category: General Medicine Source Type: news

Definitions of Endpoints for RCTs of Ulcerative Colitis Definitions of Endpoints for RCTs of Ulcerative Colitis
The authors propose the collaborative development of a core outcome set to standardize efficacy and safety reporting in ulcerative colitis RCTs, providing a conceptual framework for such development.Clinical Gastroenterology and Hepatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 30, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Pfizer Announces U.S. FDA Approves Xeljanz (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis
Wednesday, May 30, 2018 - Pfizer Inc. announced today that the United States (U.S.) Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) 10 mg twice-daily (BID) for at least eight weeks, followed by Xeljanz 5 mg BID or 10 mg BID, for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 30, 2018 Category: Drugs & Pharmacology Source Type: news

Is Verily Making a Blood Collection Device Involving & #039;Exploding & #039; Micro-Needles?
According to a CNBC report, Verily is developing a wearable blood collection device using micro-needles and magnets in an effort to make blood collection less painful and obnoxious for patients who need to be frequently monitored. The news report cites unnamed sources who said the concept has already been tested with a watch, but the project is still years away from reaching the market. Apparently, the device would include micro-needles that would "explode" into the user's skin, then be retracted by magnets for future use. The report noted that the long-term project company faces significant scientific, technical...
Source: MDDI - May 16, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: R & D Source Type: news

Fibrosis in Ulcerative Colitis and Mucosal Inflammation Fibrosis in Ulcerative Colitis and Mucosal Inflammation
This study investigated ulcerative colitis-associated fibrosis and its possible link to clinical parameters.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 15, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

InDex Pharmaceuticals Develops Oral Formulation of Cobitolimod
STOCKHOLM, May 4, 2018 -- (Healthcare Sales & Marketing Network) -- InDex Pharmaceuticals Holding AB (publ) today announced that it has developed a novel formulation of its lead drug candidate cobitolimod for oral administration, with targeted delivery to... Biopharmaceuticals, Gastroenterology InDex Pharmaceuticals, cobitolimod, ulcerative colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 4, 2018 Category: Pharmaceuticals Source Type: news

You Asked: What Is Inflammation, And Why Should I Care About It?
Your body can heal itself, which is pretty miraculous when you sit back and think about it. If you suffer a cut or infection—or if a disease, allergen or virus finds its way into you—your immune system reacts by sending specialized white blood cells to the affected area. These white blood cells can repair damage, stop the spread of infection or illness and in some cases eradicate the intruder. This whole response is called inflammation. “Inflammation is an activation of cells and cell-derived components that have the job of fighting invasions, and in some cases just sponging up or clearing out damaged cel...
Source: TIME: Health - April 11, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthytime medicine Source Type: news

Autofluorescence vs Chromoendoscopy for Dysplasia Surveillance in UC Autofluorescence vs Chromoendoscopy for Dysplasia Surveillance in UC
Autofluorescence imaging is inferior to chromoendoscopy for detecting neoplasms in patients with long-standing ulcerative colitis (UC), according to results from the FIND-UC trial.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - April 9, 2018 Category: Pathology Tags: Gastroenterology News Source Type: news

Analysis challenges link between pain medications and inflammatory bowel disease
(Wiley) Contrary to generally accepted belief, a recent review and analysis of published studies did not reveal a consistent association between the use of nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen and exacerbation of Crohn's disease and ulcerative colitis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2018 Category: International Medicine & Public Health Source Type: news

Tofacitinib and Biological Therapies for Ulcerative Colitis Tofacitinib and Biological Therapies for Ulcerative Colitis
Tofacitinib is currently under review as induction and/or maintenance therapy for adult patients with moderate-to-severe ulcerative colitis. How does it compare with other biologics?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 27, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

EMA Committee Backs Remicade Biosimilar Zessly EMA Committee Backs Remicade Biosimilar Zessly
The committee favors marketing the infliximab biosimilar product Zessly for treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and psoriasis.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 23, 2018 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Higher dose of Arena Pharma's bowel disease drug meets study goal
(Reuters) - Arena Pharmaceuticals Inc said on Monday a higher dose of its experimental drug succeeded in improving symptoms associated with ulcerative colitis, a chronic bowel disease, in a mid-stage study. (Source: Reuters: Health)
Source: Reuters: Health - March 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Panel Backs Proposed Tofacitinib Dosing for Ulcerative Colitis FDA Panel Backs Proposed Tofacitinib Dosing for Ulcerative Colitis
Pfizer scored a win in its efforts to move forward a delayed application for new use of its rheumatoid arthritis drug for treating chronic inflammation of the colon.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 9, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

FDA Panel Backs Higher Tofacitinib Dose in Ulcerative Colitis
(MedPage Today) -- Drugmaker seeks new indication for oral JAK inhibitor (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 8, 2018 Category: Gastroenterology Source Type: news

FDA panel backs Pfizer's Xeljanz as bowel disease treatment
(Reuters) - Pfizer Inc's Xeljanz should be approved to treat patients with moderate to severe ulcerative colitis, a chronic bowel disease, a U.S. Food and Drug Administration (FDA) advisory committee concluded on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - March 8, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Diverticulitis vs Ulcerative Colitis UC
Diverticular Disease (Diverticulitis) vs. Ulcerative Colitis (UC) (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 6, 2018 Category: General Medicine Source Type: news

First- and Second-line Therapy for Moderate-severe UC First- and Second-line Therapy for Moderate-severe UC
This study assessed the comparative efficacy and safety of different therapies as first-line and second-line agents for moderate-severe ulcerative colitis. What is the optimal regimen?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Vedolizumab Emerges as Option in IBD After Anti-TNF Failure Vedolizumab Emerges as Option in IBD After Anti-TNF Failure
The management of anti-TNF-resistant patients is an important clinical challenge, but new data suggest that vedolizumab helps mucosal healing in Crohn's disease and ulcerative colitis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 16, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Medical cannabis significantly safer for elderly with chronic pain than Opioids
(American Associates, Ben-Gurion University of the Negev) The new study, published in The European Journal of Internal Medicine, found cannabis therapy is safe and efficacious for elderly patients who are seeking to address cancer symptoms, Parkinson's disease, post-traumatic stress disorder, ulcerative colitis, Crohn's disease, multiple sclerosis, and other medical issues. After six months, more than 18 percent of patients surveyed had stopped using opioid analgesics or had reduced their dosage. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2018 Category: International Medicine & Public Health Source Type: news

Efficacy of Fecal Microbiota Transplant in Refractory UC Efficacy of Fecal Microbiota Transplant in Refractory UC
Could the microbial composition of donor stools influence why some therapy refractory ulcerative colitis patients respond well to fecal transplantation, while others do not?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 9, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Medical News Today: 10 rashes caused by ulcerative colitis
This article looks at skin conditions that are related to ulcerative colitis, including psoriasis, vitiligo, and hives. Learn about causes and prevention. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 18, 2018 Category: Consumer Health News Tags: Dermatology Source Type: news

Colon Cancer Symptoms vs Ulcerative Colitis
Colon Cancer Symptoms vs. Ulcerative Colitis Differences and Similarities (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 12, 2018 Category: General Medicine Source Type: news

Tofacitinib: Emerging Therapy for Ulcerative Colitis? Tofacitinib: Emerging Therapy for Ulcerative Colitis?
Will tofacitinib change the treatment landscape of ulcerative colitis?Medscape Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 11, 2018 Category: Consumer Health News Tags: Gastroenterology Commentary Source Type: news

Biologicals not cost effective for ulcerative colitis
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - January 1, 2018 Category: Drugs & Pharmacology Source Type: news

One third of antidepressants are prescribed for something else
It was when he became a father that Michael Briggs resolved to somehow bring his ulcerative colitis under control. (Source: CNN.com - Health)
Source: CNN.com - Health - December 19, 2017 Category: Consumer Health News Source Type: news

One-third of antidepressants are prescribed for something else
It was when he became a father that Michael Briggs resolved to somehow bring his ulcerative colitis under control. (Source: CNN.com - Health)
Source: CNN.com - Health - December 19, 2017 Category: Consumer Health News Source Type: news